SC
EXAS

Stephens Consulting’s Exact Sciences EXAS Stock Holding History

Stephens Consulting’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-123
Closed -$6.73K – 494
2025
Q3 		$6.73K Buy
123
+118
+2,360% +$5.9K ﹤0.01% 257
2025
Q2 		$266 Buy
+5
New +$254 ﹤0.01% 1016
2022
Q2 		– Sell
-120
Closed -$8.39K – 553
2022
Q1 		$8.39K Hold
120
– – 0.01% 371
2021
Q4 		$9.34K Buy
+120
New +$10.6K 0.01% 408

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Stephens Consulting's EXAS Position: Q4 2025 in Review

Stephens Consulting sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 123 shares — an estimated $6.73K sold.

Stephens Consulting first reported a position in EXAS in Q4 2021 and held it in 4 quarters. The position peaked at $9.34K in Q4 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Stephens Consulting reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Stephens Consulting sold 123 Exact Sciences shares in Q4 2025, an estimated $6.73K.
  • Stephens Consulting first reported a position in Exact Sciences in Q4 2021 and held it in 4 quarters.
  • Stephens Consulting's Exact Sciences position peaked at $9.34K in Q4 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.